The Effect of Amifostine on the in Vitro Cytotoxicity of Chemotherapeutic Agents in Three Epithelial Ovarian Carcinoma Cell Lines
- 30 November 1999
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 75 (2) , 194-197
- https://doi.org/10.1006/gyno.1999.5545
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintainedEuropean Journal Of Cancer, 1997
- WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cellsEuropean Journal Of Cancer, 1996
- Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.Journal of Clinical Oncology, 1996
- Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeksCancer Chemotherapy and Pharmacology, 1995
- Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated miceEuropean Journal Of Cancer, 1994
- Chemosensitivity testing in ovarian cancerCancer, 1993
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Application of an ATP-bioluminescence assay in human tumor chemosensitivity testingGynecologic Oncology, 1988